Provided by Tiger Trade Technology Pte. Ltd.

Bicara Therapeutics

18.68
+0.52002.86%
Pre-market: 18.61-0.0700-0.37%08:36 EDT
Volume:364.88K
Turnover:6.87M
Market Cap:1.18B
PE:-8.39
High:19.50
Open:18.55
Low:18.36
Close:18.16
52wk High:20.25
52wk Low:7.80
Shares:63.19M
Float Shares:24.13M
Volume Ratio:0.63
T/O Rate:1.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2271
EPS(LYR):-4.0460
ROE:-26.64%
ROA:-18.59%
PB:2.93
PE(LYR):-4.62

Loading ...

Oct 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2025

Major Issues Report

Form 8-K - Current report
Jun 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2025

Major Issues Report

Form 8-K - Current report
Jun 06, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2025

Major Issues Report

Form 8-K - Current report
Mar 28, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2025

Major Issues Report

Form 8-K - Current report
Mar 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]